Overview

BOTOX® Treatment in Pediatric Lower Limb Spasticity

Status:
Completed
Trial end date:
2017-06-28
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) in pediatric patients with lower limb spasticity.
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA